1. Clinical Contribution of PET/CT in Myeloma: From the Perspective of a Radiologist 
Yuji Nakamoto 
Clinical Lymphoma, Myeloma and Leukemia 
Volume 14, Issue 1, Pages (February 2014)
DOI: /j.clml
Copyright © 2014 Elsevier Inc. Terms and Conditions

2. Figure 1
A 45-Year-Old Woman With Multiple Myeloma. Maximum Intensity Projection Images of (A) FDG-PET and (B) MET-PET are Shown. Mild to Moderate Uptake in the Right rib and Intense Uptake in Vertebra and Right Femur are Visible in the FDG-PET Image, Suggesting Viable Lesions of Myeloma. MET-PET Also Shows Viable Lesions as Hypermetabolic Areas of 11C-MET. More Lesions are Depicted Using MET-PET Especially in the Pelvic Bones and Bilateral Femurs, Which are Unclear in the FDG Image. It Should be Noted That More Intense Physiological Uptake in Liver and Pancreas is Observed in MET-PET, and MET Uptake in the Brain is Faint, Compared With FDG-PET
Abbreviations: FDG = 18F-fluorodeoxyglucose; MET = methionine; PET = positron emission tomography.
Clinical Lymphoma, Myeloma and Leukemia  , 10-11DOI: ( /j.clml )
Copyright © 2014 Elsevier Inc. Terms and Conditions